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LDDIO R I G I N A L  A R T I C L E
Physicochemical studies of binary eutectic of ibuprofen 
and ketoprofen for enhanced transdermal drug delivery
Permeation of binary eutectic of ibuprofen and ketoprofenXudong Yuan1 and Anthony Cesare Capomacchia2
1Department of Pharmaceutical Sciences, Arnold & Marie Schwartz College of Pharmacy and Health Sciences, 
Long Island University, Brooklyn, NY, USA and 2Department of Pharmaceutical and Biomedical Sciences, 
College of Pharmacy, University of Georgia, Athens, GA, USA
Abstract
Methods: The thermodynamic, eutectic, and crystalline properties of ibuprofen and ketoprofen binary mix-
tures were investigated using differential scanning calorimetry (DSC) and X-ray powder diffractometry
(XRPD). Results: The DSC studies showed that melting point (61°C), enthalpy (11.3 kJ/mol), and entropy of
fusion (33.7 J/K/mol) of the binary eutectic were significantly lower than those of the individual anti-inflam-
matory drugs (NSAIDs). Due to the melting-point depression and enhanced skin lipid solubility, the steady-
state flux of ibuprofen and ketoprofen from preparations of the binary eutectic increased as compared to
pure NSAIDs using shed snakeskin as a model membrane. The NSAID membrane flux values were calculated
by flux ratio equations based on drug thermodynamic data, and compared to experimental values obtained
from permeation studies. Conclusion: The proposed flux ratio equations correctly predicted flux increase.
Key words: Differential scanning calorimetry (DSC); eutectic; mathematical model; NSAID; transdermal drug 
delivery; X-ray powder diffractometry (XRPD)
Introduction
Ibuprofen and ketoprofen are among the most widely
used nonsteroidal anti-inflammatory drugs (NSAIDs)
and have been used as topical preparations for treating
both rheumatoid, osteoarthritis, and related diseases1.
In the United States, it was estimated that these condi-
tions afflict over 40 million patients, or about one in
every six people, making it one of the most prevalent
diseases in the country2. Oral dosage forms of NSAIDs
usually upset the stomach and can cause nausea and
kidney toxicity. Much research has been directed
toward the development of these drugs as topical for-
mulations to overcome the adverse effects associated
with oral dosing to enhance their efficacy topically3–6.
Among many factors that could affect the perme-
ation of NSAIDs and other drugs through the skin, a
particularly important factor is the intrinsic solubility of
drug in skin lipids, which is also related to the physico-
chemical and thermodynamic properties of the drug. It
has been shown that the melting points of some drugs
are inversely proportional to their lipophilicity (log p)
and solubility in skin lipids and thus to their transder-
mal flux7. Based on the ideal solution theory, Kasting
proposed the following equation to describe the relation-
ship between transdermal permeation and melting point
of the drug permeant8 in which the ideal solubility, Sideal,
of a penetrant in skin lipids could be estimated as shown in
Equation (1):
where, r is the density of skin lipids and M1 is the aver-
age lipid molecular weight; Mw is the molecular weight of
the permeant; R is the gas constant; Tm is the permeant
melting point, and T is the solution temperature, each in
degrees Kelvin; and ΔSf is the entropy of fusion of the
permeant. The Sideal was then entered into a proposed
model to predict the steady-state flux (Jm) from its molec-
ular weight and the melting point of the permeant:
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D0 is a parameter related to diffusion coefficient D by
D = D0 exp(-bv), where v is molecular van der Waals
volume, b is a parameter related to the skin properties,
and h is the thickness of skin. v is the property of the
permeant, while D0, b, and h are properties of the skin.
The values of these parameters are estimated, and
Equation (2) is simplified as:
Since the ΔSf in Equation (1) varies slowly with melt-
ing point, Sideal increases with decreasing melting point
for any given molecular weight8. It follows that there
should be an increase in transdermal flux Jm when the
melting point decreases, all other factors being equal. In
another report, also based on the ideal solution theory,
Touitou proposed a melting temperature-membrane
transport (MTMT) concept to predict relative transder-
mal flux as a function of melting temperatures9. The sol-
ubility, in terms of mole fraction solute, X, of a permeant
in a given solvent was then related to permeant melting
temperature, Tm, and the enthalpy of fusion, ΔH:
R is the gas constant and T is temperature of per-
meant solution. The above equations indicate that a
depression in the melting point of a permeant would
increase its solubility in skin lipids and thus enhance
transdermal permeation. Therefore, if the melting point
of a drug can be reduced without causing unfavorable
changes to other physicochemical parameters, trans-
dermal flux should be increased accordingly. A method
by which the melting point of a compound can be
reduced without chemical modification is through
eutectic formation10,11. By definition, a binary eutectic
is a mixture of two components that do not interact with
each other to form a new chemical entity, but which at
certain ratios can inhibit the crystallization process of
one another, resulting in a system with a lower melting
point than either of the components. The term ‘eutectic’
comes from the Greek eutektos, meaning ‘easily
melted’. It has been shown that solid drugs of local
anesthetics can be transformed into an oily state by
depressing melting points of the compounds below
ambient temperature (25°C). In this way, the eutectic
preparation provides maximum thermodynamic activity
for the drugs12,13. The eutectic mixture can be further
emulsified and used as a topical anesthetic formulation14.
Eutectic mixtures of lidocaine, ibuprofen with menthol,
thymol, and dodecanol were also used for improved
solubility and transdermal delivery15–17.
In this study, the melting point depression and ther-
modynamic properties of the binary eutectic of ibupro-
fen and ketoprofen were investigated using differential
scanning calorimetry (DSC). The relationship between
crystalline structures of these two pure NSAIDs and
their binary eutectic was also investigated using X-ray
powder diffractometry (XRPD). Furthermore, in vitro
permeation studies using shed snakeskin as a model
membrane were conducted to study the effects of melt-
ing-point depression caused by eutectic formation on
percutaneous absorption and to obtain experimental
steady-state fluxes of the NSAIDs. The experimentally
derived steady-state fluxes were compared to those
predicted by the two proposed mathematical models
with a goal of proving the predictive capability of the
two models on NSAID permeation.
Materials and methods
Materials
The following chemicals were obtained from commer-
cial sources and used as received: ibuprofen, ketoprofen
(Sigma Chemical Co., St. Louis, MO, USA), isopropyl
alcohol (IPA), high-performance liquid chromatogra-
phy (HPLC) grade acetonitrile (ACN), potassium phos-
phate monobasic, sodium citrate dibasic, hydrochloric
acid, citric acid, sodium phosphate monobasic, sodium
phosphate dibasic, phosphoric acid (J.T. Baker Chemi-
cal Co., Phillipsburg, NJ, USA). Distilled, deionized
water was prepared by Milli Q system (Millipore Corpo-
ration, Bedford, MA, USA). Shed snakeskin was donated
by the Sandy Creek Nature Center (Athens, GA, USA).
Differential scanning calorimetry studies of binary 
mixture of ibuprofen and ketoprofen
A binary eutectic mixture was prepared according to our
previous studies18. Briefly, ibuprofen (40 mg) was mixed
with ketoprofen (60 mg) in a test tube and then the mix-
ture was heated in a water bath at 100°C. To achieve
complete mixing, the mixtures were melted in test tubes
on water bath at 100°C. The complete molten state of
mixtures was confirmed by visual inspection. After vor-
texing for one minute, the melts were left in the refriger-
ator for 3 days. A spatula was used to blend the glassy
melt to help homogeneous mixing and promote crystal-
lization of the melts. Approximately 5.0 mg of each sam-
ple was sealed into aluminum sample pans for DSC
analysis. A Perkin Elmer differential scanning calorime-
ter (Norwalk, CT, USA) equipped with Perkin Elmer TAC
7/DX thermal analysis controller was used with carrier
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gas N2 at a pressure of 20 psi. The DSC was calibrated
with indium according to the Perkin Elmer protocol
before use. Thermograms were obtained at a heating
rate of 1°C/min against an empty reference pan. The
normal and reverse heat flow DSC scanning range was
between 20°C and 100°C. The integration of peak area,
peak temperature, onset time, enthalpy (ΔH), and
entropy (ΔS) of fusion of ibuprofen, ketoprofen, and
their binary eutectic were either recorded using the
Perkin Elmer Pyris software package or calculated (ΔG =
ΔH – TΔS) as shown in Table 1 and Figure 1.
X-ray powder diffractometry studies of binary eutectic 
of ibuprofen and ketoprofen
For XRPD studies, ibuprofen (400 mg) was mixed with
ketoprofen (600 mg) and heated in a water bath at 100°C.
After melting, the mixture was vortexed for 1 minute.
After congealing in the refrigerator for 3 days, the solid
eutectic was crushed into fine particles by mortar and
pestle and mixed well using a spatula. Approximately
500 mg of the powder mixture was loaded onto a glass
sample holder and subjected to the XRPD. Pure ibupro-
fen and ketoprofen were loaded on the glass sample
holders as received, without further processing. The X-
ray powder diffractograms of pure ibuprofen, ketopro-
fen, and their binary eutectic were obtained by a Scintag
XDS 2000™ diffractometer (Scintag Inc., Cupertino, CA,
USA) with Co-Ka radiation. Scintag diffractometer was
calibrated according to the manufacturer’s protocol
before use. The data were collected at the step scan rate
of 0.06 min–1 with a step size 0.03 over a 2q range of 2–50°.
A combined XRPD pattern was generated from the raw
XRPD data of ibuprofen and ketoprofen by using
Microsoft Excel (Office 2000, Microsoft) program.
In vitro membrane permeation studies
The in vitro permeation rates of ibuprofen, ketoprofen,
and binary eutectic in select preparations were deter-
mined using shed snakeskin as a model membrane. A
whole piece of skin was cut into small circular pieces of
approximately 2.5 cm diameter. The skin samples,
which were left in distilled water for 30 minutes to allow
for complete hydration, were carefully mounted onto
Franz diffusion cells with the dorsal side facing the
donor compartment18,19. The following three sets of
preparations (A, B, C) were prepared:
A. Unsaturated IPA solutions I, II, III: ibuprofen (40
mg), ketoprofen (60 mg), and binary eutectic mixture
(40 mg of ibuprofen and 60 mg of ketoprofen) were
dissolved in 2 mL of 50% IPA solution containing cit-
rate buffer (pH 4.0) respectively.
B. Saturated IPA solutions IV, V, VI: ibuprofen (40 mg),
ketoprofen (60 mg), and the binary eutectic (40 mg of
ibuprofen and 60 mg of ketoprofen) were suspended
in 1 mL of citrate buffer (pH 4.0) respectively; then IPA
were used to convert the suspension of drug crystals
into saturated solutions after vigorous vortexing. The
concentration of ibuprofen is 23 mg/mL in solution IV.
The concentration of ketoprofen is 38 mg/mL in solu-
tion V. The concentration of ibuprofen and ketoprofen
in solution VI are 24 and 37 mg/mL respectively.
C. Saturated aqueous solutions VII, VIII, IX: ibuprofen
(40 mg), ketoprofen (60 mg), and the binary eutectic
(40 mg of ibuprofen and 60 mg of ketoprofen) were
suspended into 1 mL of buffer (pH 4.0) respectively.
The solubility of ibuprofen and ketoprofen are 0.058
and 0.28 mg/mL at pH 4.0.
Each of these preparations (I–IX) was placed in the
Franz cell donor compartments and covered with
parafilm (American National Can, Neenah, WI) to
avoid evaporation of the vehicle. The receptor com-
partments were filled with 0.05 M phosphate buffer
(pH 7.4) and maintained at 32 ± 1°C by circulating
water from a thermostat pump (Haake, Model F4391,
Berlin, Germany). The receiver phase was continu-
ously stirred at 300 rpm using a star head magnetic stir-
ring bar. The effective diffusion area of the skin was 2.0
cm2, and the volume of the receptor compartment was
6.0 cm3. Each test was replicated three times. During the
8 hours of the permeation, 200 μL of the receptor phase
Table 1. Thermodynamic data for ibuprofen, ketoprofen, and their
binary eutectic (n = 4, ± SD).
Drug Ibuprofen Ketoprofen Binary eutectic
Melting point (K) 347.6 ± 0.46 366.3 ± 0.88 335.2 ± 1.78
Enthalpy (kJ/mol) 25.3 ± 0.15 20.3 ± 0.17 11.3 ± 0.26
Entropy (J/K/mol) 72.8 ± 0.39 55.5 ± 0.48 33.7 ± 0.81
Figure 1. DSC reverse heat flow thermogram of binary eutectic of
ibuprofen and ketoprofen.
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was periodically transferred into HPLC autosampler
vials using a micro-syringe, and immediately replaced
with fresh buffer solution. After the sample was taken,
20 μL of the internal standard (pentobarbital acid
solution) and 1.0 mL of 20% ACN solution were placed
into the HPLC vials and vortexed. Steady-state flux, Jss
(μg/cm2/h), values for ibuprofen and ketoprofen were
calculated using Fick’s first law: Jss = ΔM/SΔt where S
is the effective diffusion area (cm2); ΔM/Δt is the
amount of NSAID penetrating through the membrane
per unit time at steady state (μg/h). One-way ANOVA
test was performed with SAS statistical package to
determine significant differences of Jss between prepa-
rations I–IX.
HPLC analysis of ibuprofen and ketoprofen
The Waters HPLC system (Waters, Milford, MA, USA),
which consisted of a Model 616 solvent delivery pump,
a Model 600S controller, a Model 717plus autosampler
equipped with a temperature-controlled rack, a photo-
diode array UV detector, and a Millennium data station,
was used to collect and process the data. Ibuprofen,
ketoprofen, and internal standard (pentobarbital acid)
were separated on a Waters C-18 analytical column (250
× 4.6 mm I.D., 5 μm, Waters) at ambient temperature.
The mobile phase was 50:50 (v/v) acetonitrile : phos-
phate buffer (0.025 M, pH 2.0). The flow rate was set at
1.0 mL/min. Absorbance was monitored at 223 nm
using a photodiode array UV detector. The automated
injection volume was 20 μL for each sample. Weekly
calibrations using the peak height ratios of NSAIDs over
internal standard pentobarbital acid were obtained for
concentrations in the range 20 ng/mL to 2 mg/mL. 
Results and discussion
Differential scanning calorimetry studies of binary 
eutectic of ibuprofen and ketoprofen
DSC is widely used to determine the thermochemical
properties of unknown mixtures or poorly characterized
phases. The calorimeter-equipped DSC instrument can
accurately measure endothermic or exothermic heat
flow of the sample undergoing a phase change, as well as
heat capacity of the sample. The DSC thermograms for
the binary mixtures of ibuprofen and ketoprofen showed
the significantly depressed melting points compared to
the pure compounds, and clearly indicated eutectic for-
mation (Figure 1). Reverse heat flow DSC of eutectic mix-
ture of ibuprofen and ketoprofen showed no peak in the
cooling cycle, which means the melt does not crystallize
quick enough to give an exothermic peak and takes much
longer before the melt or amorphous solid crystallizes
again. In fact, the melt remains amorphous even after
being stored for 3 days in a refrigerator; it will only solid-
ify after the crystallization process is promoted by stirring
with a spatula. Thermodynamic data obtained from DSC
(ΔG = ΔH – TΔS) are contained in Table 1; enthalpy and
entropy of fusion for the binary eutectic were signifi-
cantly lower than those of the pure ibuprofen and keto-
profen. The thermodynamic data was used in
conjunction with the models proposed by Kasting and
Touitou to derive two new equations designed to predict
the ratio of NSAID flux through skin8,9.
Combining Equations (1) and (3), the following
Equation (5) is obtained and flux through the mem-
brane of a permeant like the NSAIDs employed may be
estimated if each of the parameters is substituted into
the equation below:
Equations (1), (2), and (5) show that with other con-
ditions being equal, a lower drug melting point (Tm)
increases solubility (Sideal) in skin lipids, and results in
greater flux (Jm) through the skin. Eutectic formation is
an effective way to depress the melting point of the
NSAIDs without changing their chemical properties,
and thus can be used to enhance their membrane trans-
port. If the depressed melting point of the NSAID in the
eutectic, the solubility of drug in skin lipids, and NSAID
flux from the eutectic through the skin are denoted as
Tm
′, Sideal
′, and Jm
′ respectively, Equation (6) can be
derived from Equations (2) or (3) because Mw is con-
stant for the same NSAID. 
Thus, the increased flux offered by the eutectic over the
individual NSAID may be calculated as a ratio of Jm
′/Jm
using Equation (7), [U4]which is our first equation to pre-
dict flux from available literature or experimental data:
It is difficult to accurately measure the average
molecular weight of human stratum corneum skin lipids
(Ml) due to their number and complexity. Therefore,
their average molecular weight (604.6 g/mole) was
estimated as shown in Table 220. Equation (7) was then
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used to theoretically calculate NSAID solubility ratio
(Sideal
′/Sideal) and flux ratio (Jm
′/Jm) of the two individual
NSAID after substituting experimental, thermody-
namic, and molecular weight data. For ibuprofen and
ketoprofen, Jm
′/Jm ratios were found to be 3.64 and 3.74,
respectively, as shown in Table 3. These values are
greater than those obtained experimentally and will be
discussed below.
Based on the MTMT concept theory, if drug solu-
bility as mole fraction and the enthalpy of fusion of
the binary eutectic system are denoted as X′ and ΔH′,
respectively, Equation (8) can be obtained from
Equation (4):
Thus, the ratio of drug flux increase can be expressed
as:
Equation (9), our second predictive equation, can be
used to predict the ratio of drug solubility (X′/X) in skin
lipids and the ratio of NSAID fluxes (Jm′/Jm) if relevant
thermodynamic data are known. For ibuprofen and
ketoprofen, Jm′/Jm of 2.59 and 2.78 respectively were
obtained as shown in Table 3. The difference in the cal-
culated values between Equations (7) and (9) could be
attributed to the fact that the Equation (9), based on
MTMT theory, has no terms for permeant molecular
weight (Mw) and stratum corneum lipid molecular
weight (Ml) as found in Equation (7) from Kasting’s
model.
X-ray powder diffractometry studies of binary eutectic 
of ibuprofen and ketoprofen
In XRPD, the crystalline unit-cell edge length in a pow-
dered microcrystalline sample can be determined. The
tiny crystals in the powdered microcrystalline sample
have random orientation and, for any given set of
planes, some of the tiny crystals will be oriented at the
value of q that satisfies the Bragg equation and gets a
Bragg reflection from each of unit-cell planes. The
X-rays reflected from a plane make an angle 2q with the
direction of incident beam, so the diffraction angles are
readily measured to give a distinct diffraction pattern
for the crystalline substance measured. The same crys-
talline substance always gives the same pattern, while
in a mixture of substances, each produces its own pat-
tern independent of the others. Therefore, the X-ray dif-
fraction pattern of a substance is like its own fingerprint.
The obtained XRPD patterns of ibuprofen, ketoprofen,
and their binary eutectic are shown in Figures 2–4,
respectively. If the binary eutectic of ibuprofen and
ketoprofen formed a new crystalline lattice structure,
the X-ray crystallography would show a distinct XRPD
Table 2. Compositiona (weight percentage) and molecular weights
(MW) of human stratum corneum lipids.
Constituents
Weight 
percentage (%) MW
Average MW 
in skin lipid
Ceramide 1 14 1011 141.5
Ceramide 2 4.3 649 27.9
Glucosylceramides Trace N/A N/A
Stearic acid 1.9 284.5 5.4
Palmitic acid 7.0 256.5 18.0
Myristic acid 0.7 228.4 1.6
Oleic acid 6.3 282.5 17.8
Linoleic acid 2.4 280.5 6.7
Palmitoleic acid 0.7 254.4 1.8
Other fatty acids < 0.1 N/A N/A
Cholesterol 14 386.7 54.1
Cholesteryl sulphate 1.5 466.7 7.0
Sterol/wax esters 5.4 400 21.6
Di- and triglyceridesb 25 885.4 221.4
Squalene 4.8 410.7 19.7
n-Alkanes 6.1 352 21.5
Phospholipids 4.9 787 38.6
Total 100 N/A 604.6
aMoghimi et al., 199920. bTriolein is used to estimate di- and triglycer-
ides.
Table 3. Experimental and theoretical flux ratios (Jm′/Jm) showing the increase of ibuprofen and ketoprofen permeation from binary eutectic
preparations.
Drug
A Unsaturated 
IPA solution
B Saturated IPA
solution
C Saturated 
aqueous solution
Theoretical
prediction based 
on Equation (7)
Theoretical
prediction based
on Equation (9)
Ibuprofen 1.55 2.38 2.20 3.64 2.59
Ketoprofen 1.54 2.83 2.59 3.74 2.78
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pattern different from that of both ibuprofen and ketopro-
fen. If the binary eutectic is only a physical mixture without
forming a new crystal structure, the XRPD pattern will be
simply the addition of those of ibuprofen and ketoprofen.
To achieve better resolution, Co-Ka radiation, rather than
Cu-Ka radiation, was used as the energy source.
The original XRPD data of ibuprofen and ketoprofen
were processed with Excel software to obtain the com-
bined XRPD as shown in Figure 5, which was basically
the sum of the diffraction signals of ibuprofen and keto-
profen at the corresponding diffraction range. The sig-
nal intensity (CPS) was calculated as the sum of 40% of
the intensity of ibuprofen and 60% of the intensity of
ketoprofen, according to their ratio in the binary eutec-
tic mixture. The peak around 7.5 degree in the synthe-
sized XRPD was found to be two overlapping peaks after
magnifying the signal. No other significantly different
peaks were observed between the two diffractograms.
Therefore, the XRPD pattern of the binary eutectic is
simply the addition of diffractogram of ibuprofen to that
of ketoprofen without any major proprietary peaks. In
another words, in this eutectic mixture, ibuprofen mol-
ecules have only weak interaction, which could be van
de Waals forces or hydrogen bonding with ketoprofen
molecules without forming new crystal lattices. How-
ever, the weak forces, due to the interaction of one com-
pound as an impurity in the lattice of the other,
Figure 2. X-ray powder diffraction of pure ibuprofen.
File: ibuprofen,ID:RS-Ibuprofen
Date: September 1,2003 17:17 Step : 0.030° Cnt Time: 0.500 second.
Range: 2.00- 50.00 (degree) Step Scan Rate: 0.06°/min.
CPS
3571
3285
3000
2714
2428
2142
1857
1571
1285
1000
714
428
142
2.0 5.0 8.0 11.0 14.0 17.0 20.0 23.0 26.0 29.0 32.0 35.0 38.0 41.0 44.0 47.0
Degree.
Figure 3. X-ray powder diffraction of pure ketoprofen.
File: Ketoprofen, ID: Ketoprofen
Date: September 1,2003 Step: 0.030° Cnt Time: 0.500 second.
Range: 2.00–50.00 (degree) Step Scan Rate: 0.06°/min.
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Figure 4. X-ray powder diffraction of binary eutectic of ibuprofen and ketoprofen.
File: 60%ketoprofen+40%ibuprofen, ID: Eutectic of  Ibuprofen and Ketoprofen
Date: September 1, 2003 20:41 Step: 0.030  Cnt Time: 0.500 second.
Range: 2.00 – 50.00 (degree) Step Scan Rate : 0.06°/min.
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Figure 5. Synthesized XRPD pattern from the original XRPD data of
ibuprofen (40%) and ketoprofen (60%).
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interrupted some of the regular crystal lattices of drugs
and caused these lattices to be weaker than those in
crystals of pure drugs. The decreased lattice energy due
to the interruption was responsible for decreased melt-
ing points of the compounds. At the proper ratio, the
binary mixture exhibited the lowest melting point,
which was the eutectic point of these compounds. This
melting-point depression phenomenon was clearly
observed from DSC thermograms (Figure 1). However,
it should be pointed out that not all the drug crystalline
lattices are affected; the majorities still maintain their
original lattice structures as indicated by sharp charac-
teristic peaks in XRPD diffractogram in Figure 4.
In vitro membrane permeation studies
In order to determine the effect of melting-point
depression on membrane permeation and to compare
with the results predicted by mathematical models, dif-
ferent preparations of ibuprofen, ketoprofen, and their
binary eutectic were subjected to permeation studies
using shed snakeskin as the model membrane. HPLC
was used to quantify the NSAIDs after collection from
the Franz receptor chambers. Separation of ibuprofen
(7.6 minutes), ketoprofen (3.3 minutes), and internal
standard (2.3 minutes) were achieved within a
10-minute run as shown in Figure 6. The obtained 8-
hour permeation profiles of ibuprofen and ketoprofen
are shown in Figures 7 and 8, respectively. The steady-
state fluxes of both NSAIDs were determined using
Fick’s first law and are shown in Table 4.
The flux of ibuprofen from the unsaturated aqueous
IPA Preparation I was 12.9 μg/cm2/h. The flux of keto-
profen from unsaturated aqueous IPA Preparation II
was 9.8 μg/cm2/h, while Preparation III, the unsatur-
ated aqueous IPA solution of binary eutectic, gave
higher fluxes of 20.0 μg/cm2/h for ibuprofen and 15.1
μg/cm2/h for ketoprofen. Therefore, the fluxes of ibu-
profen and ketoprofen in the solution of the binary
eutectic increased 1.55- and 1.54-fold, respectively,
compared with those in the solutions of pure drugs at
the same donor concentration. The fluxes of ibuprofen
and ketoprofen from the saturated aqueous IPA Prepa-
rations IV and V were 16.3 and 12.0 μg/cm2/h, respec-
tively. Similarly, the saturated aqueous IPA Preparation
VI of the binary eutectic showed higher permeation
rates for both ibuprofen and ketoprofen, which were
38.8 and 33.9 μg/cm2/h, respectively. The fluxes of ibu-
profen and ketoprofen in Preparation VI increased 2.38-
and 2.83-fold, respectively, as compared to those
obtained from the saturated aqueous IPA solution of
pure drugs with the same thermodynamic activity.
The fluxes of ibuprofen and ketoprofen from the sat-
urated aqueous Preparations VII and VIII were 4.6 and
3.2 μg/cm2/h, respectively, while the saturated aqueous
Preparation IX of the binary eutectic mixture showed
higher fluxes of both ibuprofen and ketoprofen, which
were 10.1 and 8.3 μg/cm2/h, respectively. Therefore, the
Figure 6. HPLC profiles (A) Ibuprofen (7.6 minutes) and internal
standard (2.3 minutes); (B) Ketoprofen (3.3 minutes) and internal
standard (2.3 minutes); (C) Ibuprofen, Ketoprofen, and internal
standard (2.3 minutes).
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fluxes of ibuprofen and ketoprofen in Preparation IX
increased 2.20- and 2.59-fold, respectively, as compared
to those obtained from the saturated aqueous solution
of pure drugs. The flux values compared between the
different preparations (I and II to III; IV and V to VI; VII
and VIII to IX), were statistically different (n = 3, P <
0.05) using one-way ANOVA performed by SAS statisti-
cal package. The observed increase in flux values may
owe to the fact that ibuprofen and ketoprofen mole-
cules are concentrated in the solid skin lipids and inter-
act in a way similar to the molecular interaction, such as
hydrogen bonding or van de Waals forces, found in a
eutectic. According to Equations (1), (2), and (5), a
lower melting point will result in higher drug solubility
in skin lipids, and therefore a higher flux through skin is
expected. Moreover, the effects of concentration and
thermodynamic activity on drug permeation are appar-
ent from Tables 3 and 4. In Table 3, saturated IPA solu-
tion with the maximum thermodynamic activity
(column B) shows higher flux ratios than unsaturated
IPA solution with lower thermodynamic activity (col-
umn A), and higher ratios than saturated aqueous solu-
tions (column C) due to higher drug concentration.
Based on the first proposed mathematical model as
shown in Equation (7), the fluxes of ibuprofen and keto-
profen were predicted to increase by 3.64- and 3.74-
fold, respectively. However, the increases obtained
from the experiments were smaller than the predicted
values. In the calculation of the predicted fluxes, the
known values of percentages and molecular weights of
human skin lipids were used instead of those of snake-
skin. This might contribute to the observed difference,
although it was shown that the structure, composition,
lipids content, and water permeability of snakeskin are
similar to those of human skin, and snakeskin is reported
to be a good model for human skin21–23. Based on the
second mathematical model shown in Equation (9) and
derived from the MTMT theory, the predicted flux
increase for ibuprofen and ketoprofen were 2.59- and
2.78-fold, respectively. These values were very close to
the experimental values obtained from the saturated
preparations of the binary eutectic, which were 2.38-
and 2.83-fold for saturated IPA Preparation VI; 2.20-
and 2.59-fold for saturated aqueous Preparation IX. In
contrast, the ratio of unsaturated solutions of Prepara-
tion III with Preparations I and II showed relatively
lower increases of only 1.55- and 1.54-fold, respectively.
This is perhaps due to the fact that thermodynamic
activities of drugs in unsaturated Preparations I, II, and
III were not proportionally lower than those in satu-
rated preparations. Therefore, the proposed models
were more applicable to predict the changes of the
potential maximal flux of drug under conditions of max-
imum thermodynamic activity. Although Equation (9)
predicted fluxes closer to experimental values than
Equation (7), both models correctly predicted an
increase of NSAID flux from depressed melting points
and increased solubility in skin lipids due to eutectic
formation. These results confirm the validity of the
Figure 7. Permeation profiles of ibuprofen through shed snakeskin
(n = 3, error bar = SD).
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Figure 8. Permeation profiles of ketoprofen through shed snakeskin
(n = 3, error bar = SD).
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Table 4. Steady-state fluxes (Jss) of ibuprofen and ketoprofen from
different preparations.
Preparation
Jss of ibuprofen
(μg/cm2/h)
Jss of ketoprofen
(μg/cm2/h)
I 12.9 N/A
II N/A 9.8
III 20.0 15.1
IV 16.3 N/A
V N/A 12.0
VI 38.8 33.9
VII 4.6 N/A
VIII N/A 3.2
IX 10.1 8.3
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proposed mathematical models for use in predicting
ketoprofen and ibuprofen flux, and perhaps other
NSAID flux through skin.
Conclusions
The study showed that the melting points of ibuprofen
and ketoprofen were mutually depressed by eutectic
formation, with reduced enthalpy and entropy of fusion
of the NSAIDs in a binary eutectic. Even though the
crystalline lattice structures of drugs were disrupted, the
binary eutectic did not form a completely new crystal-
line structure as indicated in characteristic XRPD pat-
terns. The two proposed flux ratio mathematical models
based on ideal solution theory correctly predicted
increases in steady-state fluxes of these drugs, appar-
ently as a result of melting point depression and
increased drug solubility in skin lipids. The experimen-
tally determined flux values confirmed enhanced mem-
brane permeation of these drugs due to binary eutectic
formation as predicted by the models. The study also
suggested that binary eutectic of ibuprofen and keto-
profen, potentially other NSAIDs, could be used to
develop transdermal formulations for enhanced drug
delivery.
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